Clinical Role - Payer
Pharmacy Times® is a leader in providing the latest clinical updates, patient counseling tools and innovative solutions to payers, pharmacy benefit managers, formulary chairs and directors, managed care directors, quality assurance directors, and Medicaid/Medicare directors.
In an interview with Pharmacy Times, Peter Bonis, MD, said pharmacists are instrumental in making sure that patients receive drugs that are both safe and effective.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said formulary adherence in health systems is essential for several reasons.
In an interview with Pharmacy Times, Peter Bonis, MD, chief medical officer of clinical effectiveness at Wolters Kluwer Health, said collaboration between pharmacists, physicians, and other health care workers is essential.
Yet those directly involved in caring for the underserved and uninsured see its value firsthand.
Trends and comfort levels have changed among consumers, pharmacies, and payers from 2019 to 2020 as it relates to pharmacist-provided services and value-based performance programs.
Prescriptions for evidence-based cancer drugs increased under a pay-for-performance program without significantly impacting cost of care.
State Medicaid programs and other providers will need to learn more about the age distribution of autism among adults enrolled in Medicaid, in order to better serve them.
The 340B program allows covered entities to stretch scarce federal resources to the furthest extent possible to provide patients in need with comprehensive services.
A recent study found that the US rural mortality penalty is wide and further expanding, which applies to the rural population overall, or all racial/ethnic groups combined, and for non-Hispanic whites, non-Hispanic blacks, and Hispanics individually.
The pharmacy’s mind-set should be “Let’s solve the problem” rather than being defensive and attempting to “win the argument” with a PBM audit.
Whether agreeing to an asset purchase or stock purchase in the sale of a pharmacy, the buyer must perform due diligence.
Clinical education, strong data analytics, and collaboration are the key aspects in providing patient support and access to specialty pharmaceutical manufacturers.